Mannkind (MNKD) Net Income (QoQ) (2010 - 2026)
Mannkind (MNKD) Net Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Mannkind | 1.27 Bn | 1.13 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.21% |
| Dec 31, 2025 | -299.82% |
| Sep 30, 2025 | 1,147.03% |
| Jun 30, 2025 | -95.14% |
| Mar 31, 2025 | 77.45% |
| Dec 31, 2024 | -35.80% |
| Sep 30, 2024 | 680.11% |
| Jun 30, 2024 | -118.73% |
| Mar 31, 2024 | 655.51% |
| Dec 31, 2023 | -18.25% |
| Sep 30, 2023 | 132.69% |
| Jun 30, 2023 | 46.25% |
| Mar 31, 2023 | 45.42% |
| Dec 31, 2022 | -24.36% |
| Sep 30, 2022 | 50.27% |
| Jun 30, 2022 | -11.64% |
| Mar 31, 2022 | 7.35% |
| Dec 31, 2021 | -534.00% |
| Sep 30, 2021 | 87.54% |
| Jun 30, 2021 | -175.03% |